Recent advances in animal models of chronic antidepressant effects: The novelty-induced hypophagia test
The DOI matches its Crossref record; 117 of the 117 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Baltosser, W. H., & Zar, J. H. (1996) · Ecology · doi:10.2307/2265725 · Cited by 35,166
Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants
Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., Weisstaub, N., Lee, J., Duman, R., Arancio, O., et al. (2003) · Science · doi:10.1126/science.1083328 · Cited by 4,321
Self-citationBehavioral despair in mice: a primary screening test for antidepressants.
Porsolt, R. D., Bertin, A., & Jalfre, M. (1977) · PubMed · Cited by 4,063
Psychopharmacology: The Fourth Generation of Progress
Bloom, F. E., & Kupfer, D. J. (1995) · Medical Entomology and Zoology · Cited by 2,985
Willner, P. (1997) · Psychopharmacology · doi:10.1007/s002130050456 · Cited by 1,832
Psychopharmacology: The Fourth Generation of Progress
Brophy, J. J. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03530220079046 · Cited by 1,582
Assessing antidepressant activity in rodents: recent developments and future needs
Cryan, J. F., Markou, A., & Lucki, I. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)02017-5 · Cited by 1,551
Hall, C. S. (1934) · Journal of Comparative Psychology · doi:10.1037/h0071444 · Cited by 1,347
Neuropsychopharmacology: The Fifth Generation of Progress
SAGDUYU, K. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.7.1251-a · Cited by 1,019
Cited by
Domingos da Silveira da Luz, A. C., Pereira Dias, G., do Nascimento Bevilaqua, M. C., Cocks, G., Gardino, P. F., Thuret, S., & Nardi, A. E. (2013) · Neuropsychobiology · doi:10.1159/000353269 · Cited by 3,995
Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior
Chen, Z.-Y., Jing, D., Bath, K. G., Ieraci, A., Khan, T., Siao, C.-J., Herrera, D. G., Toth, M., Yang, C., McEwen, B. S., et al. (2006) · Science · doi:10.1126/science.1129663 · Cited by 1,340
Stress, serotonin, and hippocampal neurogenesis in relation to depression and antidepressant effects
Mahar, I., Bambico, F. R., Mechawar, N., & Nobrega, J. N. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.11.009 · Cited by 694
Hippocampal Neurogenesis: Regulation by Stress and Antidepressants
Dranovsky, A., & Hen, R. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.03.082 · Cited by 663
Self-citationSchmidt, H. D., & Duman, R. S. (2007) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3282ee2aa8 · Cited by 648
Surget, A., Saxe, M., Leman, S., Ibarguen-Vargas, Y., Chalon, S., Griebel, G., Hen, R., & Belzung, C. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.02.022 · Cited by 556
Self-citation5-HT1A autoreceptor levels determine vulnerability to stress and response to antidepressants
Richardson-Jones, J. W., Craige, C. P., Guiard, B. P., Stephen, A., Metzger, K. L., Kung, H. F., Gardier, A. M., Dranovsky, A., David, D. J., Beck, S. G., et al. (2010) · Neuron · doi:10.1016/j.neuron.2009.12.003 · Cited by 450
Self-citationIs it time to reassess the BDNF hypothesis of depression?
Groves, J. O. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4002075 · Cited by 404
Peripheral BDNF Produces Antidepressant-Like Effects in Cellular and Behavioral Models
Schmidt, H. D., & Duman, R. S. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.114 · Cited by 403
Serotonin in Affective Control
Dayan, P., & Huys, Q. J. M. (2009) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.051508.135607 · Cited by 381
Wallace, D. L., Han, M.-H., Graham, D. L., Green, T. A., Vialou, V., Iñiguez, S. D., Cao, J.-L., Kirk, A., Chakravarty, S., Kumar, A., et al. (2009) · Nature Neuroscience · doi:10.1038/nn.2257 · Cited by 342
The age of anxiety: role of animal models of anxiolytic action in drug discovery
Cryan, J. F., & Sweeney, F. F. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01362.x · Cited by 316
Holick, K. A., Lee, D. C., Hen, R., & Dulawa, S. C. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301399 · Cited by 310
Self-citationAnsorge, M. S., Morelli, E., & Gingrich, J. A. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3973-07.2008 · Cited by 301
Behavioral animal models of depression
Yan, H.-C., Cao, X., Das, M., Zhu, X.-H., & Gao, T.-M. (2010) · Neuroscience Bulletin · doi:10.1007/s12264-010-0323-7 · Cited by 294
Behavioral methods to study anxiety in rodents
Lezak, K. R., Missig, G., & Carlezon Jr, W. A. (2017) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2017.19.2/wcarlezon · Cited by 290
FAAH genetic variation enhances fronto-amygdala function in mouse and human
Dincheva, I., Drysdale, A. T., Hartley, C. A., Johnson, D. C., Jing, D., King, E. C., Ra, S., Gray, J. M., Yang, R., DeGruccio, A. M., et al. (2015) · Nature Communications · doi:10.1038/ncomms7395 · Cited by 289
Antidepressant effects of ketamine: mechanisms underlying fast-acting novel antidepressants
Browne, C. A., & Lucki, I. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00161 · Cited by 285
“Hyponeophagia is one of the few anxiety-related tests that are reliably attenuated following chronic, but not acute, administration of antidepressant drugs (Bodnoff et al., 1988; Dulawa and Hen, 2005).”
BackgroundBurgdorf, J., Zhang, X.-L., Nicholson, K. L., Balster, R. L., David Leander, J., Stanton, P. K., Gross, A. L., Kroes, R. A., & Moskal, J. R. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2012.246 · Cited by 284
“First, antidepressant-like effects of GLYX-13, ketamine, and fluoxetine were examined in the rat Porsolt, noveltyinduced hypophagia (NIH), and learned helplessness (LH) tests, using doses and routes of administration of ketamine and fluoxetine as positive controls at time points previously shown to produce an antidepr…”
BackgroundYu, H., Wang, D.-D., Wang, Y., Liu, T., Lee, F. S., & Chen, Z.-Y. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.5048-11.2012 · Cited by 275
Antidepressant actions of the exercise-regulated gene VGF
Hunsberger, J. G., Newton, S. S., Bennett, A. H., Duman, C. H., Russell, D. S., Salton, S. R., & Duman, R. S. (2007) · Nature Medicine · doi:10.1038/nm1669 · Cited by 270
Anxiety-Related Behaviors in Mice
Crawley, J., & Bailey, K. (2008) · Frontiers in Neuroscience · doi:10.1201/noe1420052343.ch5 · Cited by 267
The role of serotonin receptor subtypes in treating depression: a review of animal studies
Carr, G. V., & Lucki, I. (2011) · Psychopharmacology · doi:10.1007/s00213-010-2097-z · Cited by 260
Mastication of almonds: effects of lipid bioaccessibility, appetite, and hormone response
Cassady, B. A., Hollis, J. H., Fulford, A. D., Considine, R. V., & Mattes, R. D. (2009) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.26669 · Cited by 251
“Whether the more extreme conditions of 10 and 40 chews led to effects akin to novelty-induced hypophagia (55) warrants consideration.”
BackgroundZhu, X.-H., Yan, H.-C., Zhang, J., Qu, H.-D., Qiu, X.-S., Chen, L., Li, S.-J., Cao, X., Bean, J. C., Chen, L.-H., et al. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.6414-09.2010 · Cited by 227
“The NSF test, a hyponeophagia-based paradigm that provides an anxiety-related measure that is sensitive to the effects of chronic AD treatments, also exhibits considerable potential as an animal model for studying the neurobiology of the AD response (Dulawa and Hen, 2005).”
Conti, B., Maier, R., Barr, A. M., Morale, M. C., Lu, X., Sanna, P. P., Bilbe, G., Hoyer, D., & Bartfai, T. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4001897 · Cited by 204
Li, Y.-F., Huang, Y., Amsdell, S. L., Xiao, L., O'Donnell, J. M., & Zhang, H.-T. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.66 · Cited by 185
“The NSF test is a paradigm sensitive to anxiolytics and chronic antidepressants, which reduce feeding latency increased by a novel environment (Dulawa and Hen, 2005; Merali et al, 2003).”
BackgroundBDNF Val66Met impairs fluoxetine-induced enhancement of adult hippocampus plasticity
Bath, K. G., Jing, D. Q., Dincheva, I., Neeb, C. C., Pattwell, S. S., Chao, M. V., Lee, F. S., & Ninan, I. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.318 · Cited by 169
Dao, D. T., Mahon, P. B., Cai, X., Kovacsics, C. E., Blackwell, R. A., Arad, M., Shi, J., Zandi, P. P., O'Donnell, P., Knowles, J. A., et al. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.06.019 · Cited by 168
Kosten, T. A., Galloway, M. P., Duman, R. S., Russell, D. S., & D'Sa, C. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301527 · Cited by 165
Venzala, E., García-García, A. L., Elizalde, N., Delagrange, P., & Tordera, R. M. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2754-5 · Cited by 165
Optogenetic insights on the relationship between anxiety-related behaviors and social deficits
Allsop, S. A., Vander Weele, C. M., Wichmann, R., & Tye, K. M. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00241 · Cited by 150
Mineur, Y. S., Somenzi, O., & Picciotto, M. R. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.01.006 · Cited by 137
Duman, C. H., Schlesinger, L., Terwilliger, R., Russell, D. S., Newton, S. S., & Duman, R. S. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.11.016 · Cited by 123
“The NIH test provides a behavioral measure of anxiety that is sensitive to chronic but not acute antidepressant treatment, consistent with the time lag for the therapeutic action of antidepressants [17].”
BackgroundMethodBelzung, C. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2013.342 · Cited by 106
“…al, 2013 Nollet et al, 2013 Anhedonia Sucrose preference Cookie test Decreased intra-cranial selfstimulation Willner et al, 1987 Surget et al, 2011 Moreau et al, 1992 Anxiety Novelty-induced suppression of feeding behavior Dulawa and Hen, 2005 Irritability Resident-intruder test Mineur et al, 2003”
BackgroundSerotonin 2C receptor antagonists induce fast-onset antidepressant effects
Opal, M. D., Klenotich, S. C., Morais, M., Bessa, J., Winkle, J., Doukas, D., Kay, L. J., Sousa, N., & Dulawa, S. M. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.144 · Cited by 103
Self-citationSon, H., Banasr, M., Choi, M., Chae, S. Y., Licznerski, P., Lee, B., Voleti, B., Li, N., Lepack, A., Fournier, N. M., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1201191109 · Cited by 103
“Moreover, currently available antidepressants are only effective in approximately one-third of patients with MDD and in up to two-thirds after multiple trials, and they take weeks to months to produce a response (2, 3).”
BackgroundTurner, J. R., Castellano, L. M., & Blendy, J. A. (2010) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.166280 · Cited by 88
Meylan, E. M., Halfon, O., Magistretti, P. J., & Cardinaux, J.-R. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.03.012 · Cited by 87
“However, hyponeophagic behavior can be related to depressive but also anxious behavior (Dulawa and Hen, 2005) and both fluoxetine and desipramine have anxiolytic effects (Zohar and Westenberg, 2000).”
Cytisine-based nicotinic partial agonists as novel antidepressant compounds
Mineur, Y. S., Eibl, C., Young, G., Kochevar, C., Papke, R. L., Gündisch, D., & Picciotto, M. R. (2009) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.149609 · Cited by 75
Normann, C., Frase, S., Haug, V., von Wolff, G., Clark, K., Münzer, P., Dorner, A., Scholliers, J., Horn, M., Vo Van, T., et al. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.10.008 · Cited by 56
Cyclooxygenase-2 inhibition reduces stress-induced affective pathology
Gamble-George, J. C., Baldi, R., Halladay, L., Kocharian, A., Hartley, N., Silva, C. G., Roberts, H., Haymer, A., Marnett, L. J., Holmes, A., et al. (2016) · eLife · doi:10.7554/elife.14137 · Cited by 55
Huang, G.-J., Ben-David, E., Tort Piella, A., Edwards, A., Flint, J., & Shifman, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035901 · Cited by 52
“We tested whether voluntary exercise had the expected antidepressant effects by comparing exercising animals to controls in behaviors that were found to be modulated in response to fluoxetine: novelty suppressed feeding [18], marble burying and digging activity in a new environment [19] [20], and novelty induced hypop…”
BackgroundDadomo, H., Sanghez, V., Di Cristo, L., Lori, A., Ceresini, G., Malinge, I., Parmigiani, S., Palanza, P., Sheardown, M., & Bartolomucci, A. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.11.016 · Cited by 54
Phosphorylation of MeCP2 at Ser421 Contributes to Chronic Antidepressant Action
Hutchinson, A. N., Deng, J. V., Cohen, S., & West, A. E. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.2156-12.2012 · Cited by 53
“Although novel objects and social interactions are thought to confer reward in these tasks, novelty also induces stress in rodents, for example, as measured by the noveltysuppressed feeding task (Dulawa and Hen, 2005).”
BackgroundMineur, Y. S., Einstein, E. B., Seymour, P. A., Coe, J. W., O'Neill, B. T., Rollema, H., & Picciotto, M. R. (2011) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e328347546d · Cited by 49
Anxiolytic effect of serotonin depletion in the novelty-induced hypophagia test
Bechtholt, A. J., Hill, T. E., & Lucki, I. (2007) · Psychopharmacology · doi:10.1007/s00213-006-0615-9 · Cited by 48
Caldarone, B. J., Wang, D., Paterson, N. E., Manzano, M., Fedolak, A., Cavino, K., Kwan, M., Hanania, T., Chellappan, S. K., Kozikowski, A. P., et al. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2271-y · Cited by 47
Bechtholt, A. J., Valentino, R. J., & Lucki, I. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301616 · Cited by 40
“…outcomes are consistent with numerous previous reports using the novelty-suppressed feeding paradigm and a number of reports using the NIH paradigm and confirm the ability of acute benzodiazepines and chronic antidepressants to increase feeding in the NIH test (for review see Dulawa and Hen, 2005).”
InfluentialPatel, R. R., Wolfe, S. A., Borgonetti, V., Gandhi, P. J., Rodriguez, L., Snyder, A. E., D’Ambrosio, S., Bajo, M., Domissy, A., Head, S., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01642-3 · Cited by 33
Divergent Functional Effects of Sazetidine-A and Varenicline During Nicotine Withdrawal
Turner, J. R., Wilkinson, D. S., Poole, R. L., Gould, T. J., Carlson, G. C., & Blendy, J. A. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.105 · Cited by 29
Yohn, N. L., Turner, J. R., & Blendy, J. A. (2014) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.211706 · Cited by 28
“The NIH paradigm is a sensitive measure for potential anxiolytic drugs and anxiogenic effects of withdrawal on both acute and extended drug administration paradigms (Dulawa et al., 2004; Dulawa and Hen, 2005).”
BackgroundSerotonin is a common thread linking different classes of antidepressants
Witt, C. E., Mena, S., Holmes, J., Hersey, M., Buchanan, A. M., Parke, B., Saylor, R., Honan, L. E., Berger, S. N., Lumbreras, S., et al. (2023) · Cell Chemical Biology · doi:10.1016/j.chembiol.2023.10.009 · Cited by 18
Vozella, V., Cruz, B., Natividad, L. A., Benvenuti, F., Cannella, N., Edwards, S., Zorrilla, E. P., Ciccocioppo, R., & Roberto, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22063095 · Cited by 16
“Here rats were monitored for anxiety-like behavior using hypophagia procedures as previously published [48].”
Method
Metadata
- Authors
- Dulawa, S. C., & Hen, R.
- Venue
- Neuroscience & Biobehavioral Reviews
- Publisher
- Elsevier BV
- Published
- 2005-01
- Volume
- 29
- Issue
- 4-5
- Pages
- 771-783
- ISSN
- 0149-7634 (ISSN-L)
- OpenAlex
- W2033202446
- Cited by
- 430
- References
- 117
- FWCI
- 8.41
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.